News stories about Cognex (NASDAQ:CGNX) have been trending somewhat positive on Saturday, Accern reports. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cognex earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave media coverage about the scientific and technical instruments company an impact score of 46.9269458657941 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
A number of analysts have issued reports on the company. Zacks Investment Research downgraded Cognex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. JPMorgan Chase & Co. downgraded Cognex from a “neutral” rating to an “underweight” rating and set a $62.50 price objective on the stock. in a research note on Wednesday, November 8th. BidaskClub raised Cognex from a “hold” rating to a “buy” rating in a research note on Wednesday. ValuEngine downgraded Cognex from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Finally, Canaccord Genuity lifted their price objective on Cognex from $47.50 to $60.00 and gave the stock a “hold” rating in a research note on Tuesday, October 31st. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $60.17.
Cognex (NASDAQ:CGNX) traded up $0.87 during midday trading on Friday, hitting $67.91. The stock had a trading volume of 1,150,051 shares, compared to its average volume of 2,210,000. The company has a market cap of $11,760.00, a P/E ratio of 49.93 and a beta of 1.50. Cognex has a 52-week low of $32.05 and a 52-week high of $72.99.
Cognex (NASDAQ:CGNX) last released its earnings results on Monday, October 30th. The scientific and technical instruments company reported $0.57 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.05. The firm had revenue of $259.74 million for the quarter, compared to the consensus estimate of $255.95 million. Cognex had a return on equity of 23.31% and a net margin of 34.77%. The company’s revenue for the quarter was up 75.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.31 EPS. equities analysts forecast that Cognex will post 1.39 earnings per share for the current fiscal year.
In other news, Director Patrick Alias sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $143.54, for a total transaction of $717,700.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Jeffrey Benjamin Miller sold 3,750 shares of the business’s stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $134.48, for a total value of $504,300.00. Following the transaction, the director now directly owns 3,750 shares in the company, valued at approximately $504,300. The disclosure for this sale can be found here. In the last three months, insiders have sold 143,750 shares of company stock worth $18,540,975. Corporate insiders own 5.60% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Cognex (CGNX) Receives Daily News Sentiment Score of 0.12” was first reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.thelincolnianonline.com/2018/01/13/cognex-cgnx-receives-daily-news-sentiment-score-of-0-12.html.
Cognex Company Profile
Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.